RxDoctor Payments Data

Jake Hemingway, MD

Vascular Surgery · Seattle, WANPI 1952835811

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (40.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Asahi Intecc USA, Inc. at 38.1% of the total. 2025 is the largest year on record at $12,101, 7.8 times the $1,556 reported in 2022.

$14,947in general payments, 2019–2025

Across 72 payments — averaging $207.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Asahi Intecc USA, Inc.$6K
  • Abbott$5K
  • Medtronic$2K
  • Silk Road Medical, Inc.$560
  • Balt USA, LLC$395
  • Cook Medical LLC$358
  • plus $1K from 11 others
$35,131in research payments, 2019–2025

Across 1 payment — averaging $35,131 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$35K

What the payments were for

  • Consulting fees$2,62518%
  • Speaking & faculty fees$6,05040%
  • Grants$1,50010%
  • Travel & lodging$5023%
  • Food & beverage$4,27029%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,947 in reported general payments places this provider in the 85th percentile of 111 vascular surgery providers in Washington.

See all vascular surgery providers in Washington

Medicare billing

Part B allowed, 2024
$102,698
Medicare patients
457
Services billed
1,061

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →